Enhancing Existing Approaches to Peripheral T-Cell Lymphoma
To access this article, please choose from the options below
STATEMENT OF CONFLICT OF INTEREST: Dr Foss discloses the following relationships: Consulting Fees: Gloucester; Speaker's Bureaus: Merck, Cephalon, Eisai, Biogen; Honoraria: Eisai, Gloucester.
PII: S0037-1963(10)00013-2
doi:10.1053/j.seminhematol.2010.01.012
© 2010 Published by Elsevier Inc.
